Experian and OpenAI Launch the UK’s First Credit Score App Inside ChatGPT March 13, 2026 Combining the UK’s most trusted credit score with aggregated, anonymised data to give consumers contextual insights for better financial decisions This marks Experian’s latest step in promoting transparency and learning around credit scores, reinforcing its mission to “better your score, better your story” The new Experian Credit Score app is searchable in ChatGPT via @Experian UK
LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market March 12, 2026 LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step [...]
Waiv Secures $33 Million to Scale AI Precision Testing March 12, 2026 Waiv, a Paris-based startup, spins out of Owkin to accelerate AI-enabled precision oncology testing
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program March 12, 2026 — Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project — — Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings — — Application Period to Run From March 16, 2026 Through June 1, 2026 —
Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF) March 12, 2026 Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and redundant biological pathways, limiting the effectiveness of single-target approaches. Baseimmune uses advanced computational protein design to target multiple pro-fibrotic pathways simultaneously. Initially focused on IPF, where approved single-target therapies only slow lung function decline. Fibrosis pipeline advancing toward proof-of-concept efficacy readouts in 2026 and 2027. Assembled world-class Scientific Advisory Board: John Cijiang He, Scott L. Friedman, Toby Maher, Paul Noble, and Joel Rurik.
Nature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral Therapy March 12, 2026 Randomized, double-blind trial shows Limbic’s clinical reasoning layer turns leading LLMs into mental health specialists, achieving gold-standard clinical performance
NAFFCO Group and Verona Shelters Launch Strategic Joint Venture to Scale Civil and Military Shelter Production Globally March 12, 2026 NAFFCO Group has entered into a Joint Venture Agreement with Verona Shelters to form a strategic partnership dedicated to developing and manufacturing advanced civil defense and military shelter solutions in the United Arab Emirates. The partnership significantly expands global production capacity for protective shelter infrastructure at a time when governments and critical industries are strengthening [...]
Level Access Supercharges Partner Program to Accelerate Digital Accessibility March 12, 2026 IBM, Slalom, Merkle, and more will harness the power of Level Access’s platform to deliver inclusive customer experiences
Redslim expands into Asia-Pacific to support global brands with data and AI infrastructure March 12, 2026 Redslim, a specialist in end-to-end data management solutions and an Astorg portfolio company, today announced its expansion into the Asia-Pacific region and the appointment of Kyriakos Zannikos as Regional Director, APAC. The move marks an important milestone in Redslim’s global growth strategy and brings the company closer to clients operating in one of the world’s [...]
Texas Stock Exchange (TXSE) Selects Options’ AtlasInsight for Next Generation Packet Capture and Real Time Analytics March 11, 2026 Options Technology (Options), the leading provider of financial services infrastructure, today announced that its AtlasInsight platform has been selected by the Texas Stock Exchange (TXSE) to deliver high-fidelity packet capture and real-time analytics across TXSE’s proprietary, world-class trading infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311267175/en/ As TXSE prepares to launch [...]